Atenção: Todas as denúncias são sigilosas e sua identidade será preservada.
Os campos nome e e-mail são de preenchimento opcional
Metadados | Descrição | Idioma |
---|---|---|
Autor(es): dc.contributor | Universidade Federal do Pará (UFPA) | - |
Autor(es): dc.contributor | Universidade Estadual Paulista (UNESP) | - |
Autor(es): dc.contributor | Universidade Federal de São Paulo (UNIFESP) | - |
Autor(es): dc.creator | Felício, João Soares | - |
Autor(es): dc.creator | Pacheco, Juliana Torres | - |
Autor(es): dc.creator | Ferreira, Sandra Roberta [UNESP] | - |
Autor(es): dc.creator | Plavnik, Frida | - |
Autor(es): dc.creator | Moisés, Valdir | - |
Autor(es): dc.creator | Kohlmann Jr., Oswaldo | - |
Autor(es): dc.creator | Ribeiro, Artur Beltrame | - |
Autor(es): dc.creator | Zanella, Maria Tereza | - |
Data de aceite: dc.date.accessioned | 2022-08-04T22:01:41Z | - |
Data de disponibilização: dc.date.available | 2022-08-04T22:01:41Z | - |
Data de envio: dc.date.issued | 2022-04-28 | - |
Data de envio: dc.date.issued | 2022-04-28 | - |
Data de envio: dc.date.issued | 2007-10-10 | - |
Fonte completa do material: dc.identifier | http://hdl.handle.net/11449/219423 | - |
Fonte: dc.identifier.uri | http://educapes.capes.gov.br/handle/11449/219423 | - |
Descrição: dc.description | The aim of the present study was to evaluate the influence of elevated levels of nocturnal blood pressure (BP) on diabetic retinopathy (DR). A total of 88 diabetic hypertensive patients were divided according to the stage of DR. They underwent 24 h ambulatory BP monitoring and ophthalmological evaluation, and their average level of fasting blood glucose as well as their glycemic control index (percentage of fasting blood glucose higher than 11.2 mmol/L over the previous four years) were calculated. When diabetic patients with retinopathy (n=29) (group 1) were compared with patients without retinopathy (n=59) (group 2), a significant difference was observed in diabetes duration (124 months [range six to 460 months] versus 43 months [range six to 365 months], respectively; P<0.05). In addition, group 1 showed higher levels of nocturnal systolic BP (NSBP) (141±22 mmHg versus 132±18 mmHg; P<0.05). However, no significant differences were found between the two groups (group 1 and group 2) when diurnal pressoric levels were compared (diurnal systolic BP, 153±19 mmHg versus 146±19 mmHg, P not significant; and diurnal diastolic BP, 91±9 mmHg versus 91±13 mmHg, P not significant). DR correlated with diabetes duration (r=0.26; P<0.05) and with glycemic control index (r=0.24; P<0.01). Multivariate regression analysis showed NSBP to be an independent predictor of DR (r2=0.12; P<0.01). Moreover, patients with severe stages of DR (preproliferative, proliferative or macular edema) showed a lower decrease of NSBP than the other patients (3.9±6.0 mmHg versus 9.2±6.0 mmHg; P<0.05). The present study suggests that the absence of 24 h normal pressoric rhythm can interfere with the prevalence and severity of DR. © 2007 Pulsus Group Inc. All rights reserved. | - |
Descrição: dc.description | Nephrology Division Endocrinology Division Universidade Federal do Pará | - |
Descrição: dc.description | Universidade Estadual de São Paulo, São Paulo | - |
Descrição: dc.description | Universidade Federal de São Paulo, São Paulo | - |
Descrição: dc.description | Universidade Estadual de São Paulo, São Paulo | - |
Formato: dc.format | 157-160 | - |
Idioma: dc.language | en | - |
Relação: dc.relation | Experimental and Clinical Cardiology | - |
???dc.source???: dc.source | Scopus | - |
Palavras-chave: dc.subject | Ambulatory blood pressure monitoring | - |
Palavras-chave: dc.subject | Diabetic retinopathy | - |
Palavras-chave: dc.subject | Hypertension | - |
Palavras-chave: dc.subject | Type 2 diabetes mellitus | - |
Título: dc.title | Impaired reduction of nocturnal systolic blood pressure and severity of diabetic retinopathy | - |
Tipo de arquivo: dc.type | livro digital | - |
Aparece nas coleções: | Repositório Institucional - Unesp |
O Portal eduCAPES é oferecido ao usuário, condicionado à aceitação dos termos, condições e avisos contidos aqui e sem modificações. A CAPES poderá modificar o conteúdo ou formato deste site ou acabar com a sua operação ou suas ferramentas a seu critério único e sem aviso prévio. Ao acessar este portal, você, usuário pessoa física ou jurídica, se declara compreender e aceitar as condições aqui estabelecidas, da seguinte forma: